✦ LIBER ✦

Genotypic and Phenotypic Analyses of Hepatitis C Virus Variants Observed in Clinical Studies of VX-222, a Nonnucleoside NS5B Polymerase Inhibitor

✍ Scribed by Jiang, M.; Zhang, E. Z.; Ardzinski, A.; Tigges, A.; Davis, A.; Sullivan, J. C.; Nelson, M.; Spanks, J.; Dorrian, J.; Nicolas, O.; Bartels, D. J.; Rao, B. G.; Rijnbrand, R.; Kieffer, T. L.

Book ID: 127276654
Publisher: American Society for Microbiology
Year: 2014
Tongue: English
Weight: 716 KB
Volume: 58
Category: Article
ISSN: 0066-4804
DOI: 10.1128/aac.03052-14

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of hepatitis C virus variants

Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b

✍ Fumitaka Suzuki; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Yuya Seko; Yusuke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 156 KB

In Vitro Phenotypic Characterization of

In Vitro Phenotypic Characterization of Hepatitis C Virus NS3 Protease Variants Observed in Clinical Studies of Telaprevir

✍ Jiang, M.; Mani, N.; Lin, C.; Ardzinski, A.; Nelson, M.; Reagan, D.; Bartels, D. 📂 Article 📅 2013 🏛 American Society for Microbiology 🌐 English ⚖ 711 KB

Genotypic and phenotypic analysis of var

Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations

✍ Robert A. Fridell; Chunfu Wang; Jin-Hua Sun; Donald R. O'Boyle II; Peter Nower; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 1 views

The NS5A replication complex inhibitor, BMS-790052, inhibits hepatitis C virus (HCV) replication with picomolar potency in preclinical assays. This potency translated in vivo to a substantial antiviral effect in a single-ascending dose study and a 14-day multiple-ascending dose (MAD) monotherapy stu

Review article: the efficacy and safety

Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection

✍ Koff, R. S. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

[Methods in Molecular Biology] Antiviral

[Methods in Molecular Biology] Antiviral Methods and Protocols Volume 1030 || Amplification and Sequencing of the Hepatitis C Virus NS3/4A Protease and the NS5B Polymerase Regions for Genotypic Resistance Detection of Clinical Isolates of Subtypes 1a and 1b

✍ Gong, Edwin Yunhao 📂 Article 📅 2013 🏛 Humana Press ⚖ 185 KB

Benzimidazole Derivatives Bearing Substi

Benzimidazole Derivatives Bearing Substituted Biphenyls as Hepatitis C Virus NS5B RNA-Dependent RNA Polymerase Inhibitors: Structure−Activity Relationship Studies and Identification of a Potent and Highly Selective Inhibitor JTK-109

✍ Hirashima, Shintaro; Suzuki, Takayoshi; Ishida, Tomio; Noji, Satoru; Yata, Shinj 📂 Article 📅 2006 🏛 American Chemical Society 🌐 English ⚖ 223 KB